IMAX Crushes Q2 Estimates, Guides Strong H2 on Blockbuster Slate
IMAX sits 75% above its 52-week low of $24.2 on elevated volume (1.9× avg).
Summary
IMAX delivered a standout Q2, with revenue of $102.8M beating consensus by nearly 10% and adjusted EPS of $0.43 more than doubling estimates. The beat was driven by the highest Q2 box office since 2019, fueled by 24% international growth ex-China, and the most Q2 system installations in a decade. Management also repurchased $13.7M in shares, signaling confidence. Looking ahead, the company expects momentum from 'The Odyssey' and a strong H2 slate including 'Dune: Part Three' and 'Spider-Man: Brand New Day' to sustain growth. This follows a Q1 that saw profit surge but revenue dip, making the Q2 top-line acceleration a key positive shift. The results reinforce the bull case laid out in recent media coverage and the ongoing strategic review for a potential sale.
At the time of this announcement, IMAX was trading at $42.33 on NYSE in the Technology sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $24.20 to $45.52. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.